v3.26.3
SEGMENTS INFORMATION - Segment Revenue, Significant Segment Expenses and Segment Operating EBITDA (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Segment Reporting [Line Items]        
Equity in earnings (loss) of nonconsolidated affiliates $ 5 $ 0 $ 13 $ (6)
Healthcare & Water Technologies        
Segment Reporting [Line Items]        
Segment net sales 865 832 2,527 2,412
Cost of sales 532 527 1,552 1,510
Selling, general and administrative expenses 96 88 291 260
Research and development expenses 19 21 60 63
Amortization of intangibles & other segment items 44 44 130 141
Equity in earnings (loss) of nonconsolidated affiliates 0 1 2 1
Depreciation and amortization 89 93 269 278
Segment operating EBITDA 263 246 765 717
Diversified Industrials        
Segment Reporting [Line Items]        
Segment net sales 1,003 963 2,841 2,744
Cost of sales 659 643 1,872 1,837
Selling, general and administrative expenses 122 114 364 338
Research and development expenses 22 24 73 72
Amortization of intangibles & other segment items 24 22 72 74
Equity in earnings (loss) of nonconsolidated affiliates 0 (1) (1) (1)
Depreciation and amortization 66 60 196 181
Segment operating EBITDA $ 242 $ 219 $ 655 $ 603